Patents by Inventor Calvin Roskelley

Calvin Roskelley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9309323
    Abstract: Methods and kits for detecting cancer and monitoring cancer progression are described. The method involves analyzing a sample containing nucleic acids or proteins from a patient for decreased expression of endoglycan and/or increased expression of podocalyxin.
    Type: Grant
    Filed: July 24, 2009
    Date of Patent: April 12, 2016
    Assignee: The University of British Columbia
    Inventors: David Huntsman, Helen Merkens, Aruna Somasiri, Kelly M. McNagny, Calvin Roskelley
  • Patent number: 7833733
    Abstract: Methods and kits for detecting cancer and monitoring cancer progression are described. The method involves analyzing a sample containing nucleic acids or proteins from a patient for decreased expression of endoglycan and/or increased expression of podocalyxin.
    Type: Grant
    Filed: June 9, 2004
    Date of Patent: November 16, 2010
    Assignee: The University of British Columbia
    Inventors: Kelly M. McNagny, Calvin Roskelley, Helen Merkens, Aruna Somasiri, David Huntsman
  • Publication number: 20100061978
    Abstract: Methods and kits for detecting cancer and monitoring cancer progression are described. The method involves analyzing a sample containing nucleic acids or proteins from a patient for decreased expression of endoglycan and/or increased expression of podocalyxin.
    Type: Application
    Filed: July 24, 2009
    Publication date: March 11, 2010
    Inventors: DAVID HUNTSMAN, HELEN MERKENS, ARUNA SOMASIRI, KELLY M. MCNAGNY, CALVIN ROSKELLEY
  • Publication number: 20080020372
    Abstract: Methods and kits for detecting cancer and monitoring cancer progression are described. The method involves analyzing a sample containing nucleic acids or proteins from a patient for decreased expression of endoglycan and/or increased expression of podocalyxin.
    Type: Application
    Filed: June 9, 2004
    Publication date: January 24, 2008
    Applicant: The University Of British Columbia
    Inventors: Kelly M. McNagny, Calvin Roskelley, Helen Merkens, Aruna Somasiri, David Huntsman
  • Publication number: 20050222126
    Abstract: This invention provides the use of macrocyclic amines for inhibition of cellular invasion or angiogenesis. Compounds and pharmaceutical compositions of this invention are useful in the treatment of conditions characterized by cellular invasion or angiogenesis, including cancer. Compounds that may be used in this invention include the motuporamines.
    Type: Application
    Filed: February 28, 2005
    Publication date: October 6, 2005
    Inventors: Calvin Roskelley, Raymond Andersen, David Williams, Michel Roberge, Shoukat Dedhar, Aly Karsan, Andrew Minchinton
  • Publication number: 20030004149
    Abstract: This invention provides the use of macrocyclic amines for inhibition of cellular invasion or angiogenesis. Compounds and pharmaceutical compositions of this invention are useful in the treatment of conditions characterized by cellular invasion or angiogenesis, including cancer. Compounds that may be used in this invention include the motuporamines.
    Type: Application
    Filed: January 25, 2002
    Publication date: January 2, 2003
    Inventors: Calvin Roskelley, Raymond Andersen, David Williams, Michel Roberge, Shoukat Dedhar, Aly Karsan, Andrew Minchinton